首页>
外国专利>
TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR TH2-ENHANCING CYTOKINES
TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR TH2-ENHANCING CYTOKINES
展开▼
机译:口服耐受和/或增强TH2的细胞因子治疗自身免疫性疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention is directed to methods for treating autoimmune diseases such as multiple sclerosis by orally administering a bystander antigen such as myelin basic protein or proteolipid protein in conjunction with a non-interferon polypeptide having Th2-enhancing cytokine activity in such a manner as to induce oral tolerance to the bystander antigen resulting in suppression of the autoimmune response.
展开▼